Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

67Gallium lung scans in progressive systemic sclerosis.

M Baron, D Feiglin, R Hyland

    Arthritis and Rheumatism
    |August 1, 1983
    PubMed
    Summary

    Gallium-67 lung scans reveal increased uptake in patients with systemic sclerosis (scleroderma), suggesting this imaging technique may help assess pulmonary disease activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Disease course patterns in systemic lupus erythematosus.

    Lupus·2018
    Same author

    Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

    Arthritis research & therapy·2018
    Same author

    Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

    Lupus·2018
    Same author

    Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

    Lupus·2018
    Same author

    Antimalarial-induced cardiomyopathy: a systematic review of the literature.

    Lupus·2017
    Same author

    Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritis.

    Lupus·2017

    Area of Science:

    • Nuclear medicine
    • Pulmonology
    • Rheumatology

    Background:

    • Systemic sclerosis (scleroderma) is an autoimmune disease characterized by fibrosis affecting the skin and internal organs.
    • Pulmonary involvement is a common and serious complication of systemic sclerosis, often leading to significant morbidity and mortality.
    • Assessing the activity and extent of lung disease in systemic sclerosis is crucial for patient management.

    Purpose of the Study:

    • To evaluate the utility of Gallium-67 (67Ga) lung scintigraphy in patients with progressive systemic sclerosis.
    • To determine if 67Ga uptake in the lungs correlates with disease activity or other clinical parameters.
    • To establish 67Ga lung uptake as a potential biomarker for pulmonary involvement in scleroderma.

    Main Methods:

    • 19 patients diagnosed with progressive systemic sclerosis underwent Gallium-67 lung scanning.
    • Pulmonary 67Ga uptake was quantified using the Gallium Uptake Index (GUI).
    • GUI values in patients were compared to those of a control group.

    Main Results:

    • The mean total pulmonary 67Ga Uptake Index was significantly elevated in systemic sclerosis patients compared to controls (41 vs. 25).
    • Approximately 21% of patients exhibited 67Ga uptake outside the normal range.
    • No significant correlation was found between pulmonary 67Ga uptake and available clinical or laboratory variables.

    Conclusions:

    • Increased pulmonary 67Ga uptake is a common finding in patients with systemic sclerosis.
    • Gallium-67 lung scanning may serve as a valuable, non-invasive index for assessing pulmonary disease activity in scleroderma.
    • Further research is warranted to validate 67Ga uptake as a prognostic marker in systemic sclerosis-related lung disease.

    Related Experiment Videos